Medical students face a challenge with the rising tide of increasingly elderly patients. By the year 2020, people age 65 and older will outnumber children under age 5 around the globe. Additionally, by the year 2030, there will be a globally increased burden in caring for chronic noncommunicable diseases as they become the major cause for loss of health and life. As the baby boomer population begins to reach 65, elder care will become inescapable, because it will extend beyond geriatrics, pervading every medical discipline and specialty. Doctors and students alike find treating age-related degeneration to be a losing battle because existing methods cannot effectively defer the constant barrage from causative agents, a failure that ultimately results in recurrence and advancement of original and secondary afflictions. The causes of such morbidity are multifactorial and a consequence of healthy metabolism that result in an age-related degeneration. This renders the conditions impervious to the traditional prevention and curative approaches. A regenerative medicine approach to age-related degenerative disease is uniquely positioned to meet this situation because it is based around repair of damage, rather than direct intervention in highly complex metabolic processes. Here, the authors promote regenerative medicine as a prospective approach to age-related degenerative disease that is outside the limits of preventive and curative therapies that currently dominate the medical curriculum. Regenerative medicine therapies present the potential to provide care without increasing frailty, thus serving the medical ideal of restoring health rather than protracting decline. Such an approach has yet to be sufficiently impressed upon the ranks of the current medical student cohort, which is largely unaware of the demographic realities facing their careers. It is important that medical school administrators and students recognize the vast potential in regenerative medicine and actively facilitate the development and distribution of such knowledge among the medical education community. Acknowledging the need for therapies focused on aging demographics is not new. Despite decades of research in the basic science of medicine, the curative model of disease has shown itself ineffective at restoring population health. While single-factor diseases were cured with antibiotics or vaccines, such approaches have not had success when applied to multifactorial conditions such as age-related degenerative diseases. In lieu of cures, the management of degenerative disease has successfully reduced symptoms and suffering. However, disease management fails to address the underlying conditions and ultimately promotes extended morbidity, suffering, and costs. The alternative approach has been prevention. Although prevention does slow the onset of frailty by laudably attending to the underlying causes of degeneration, it does not prevent nor reverse the pathology. For senior patients presenting with such disease, many of whom having eschewed prevention in favor of the curative approaches, prevention is simply too late. Medical students must continue to promote prevention while simultaneously focusing on ways to target the damage of age-related degeneration, rather than simply continuing to manage the frail state. Emerging biotechnology does indeed give us reason to be optimistic about cures. Paradoxically, the staggering nature of our advances in understanding may represent a complexity trap. It is tempting to predict reductions in morbidity and mortality based on the genomics revolution to be commensurate with the development of antibiotics and vaccines. However, those tools were used against diseases caused by single factors. Age-related degenerative diseases are multifactorial conditions caused by a host of different genes and environmental factors that are deeply rooted within healthy metabolism. Ironically, as our technology peers ever deeper into the root causes, we may be discovering our own impotence in the face of an intractably complicated metabolism. Rather than being confident with such novel discoveries as RNA interference and the role of epigenetics, their detection should caution that we are still only scratching the surface of metabolic realities. Because cures depend on the extent to which we understand metabolism, optimism toward such curative efforts may be misplaced. The question for medical students centers on how we can target age-related degeneration in a way that improves health span. Such an approach would intervene after the appearance of signs and symptoms, but before sufficient damage has accumulated to tip the patient into overwhelming system decline; regenerative medicine is such an approach. Regenerative medicine can be applied when prevention is too late, and it sidesteps the metabolic complexity that may waylay the curative approach. Regenerative medicine therapies focus on repairing injured, lost, or aging cells in the human body and aim to restore the structure and function of tissues and organs. Disease treatment and function
Read full abstract
Dec 5, 2017
Open Access
Igor I Bussel + 3